SEC Form 4 · accession 0001683168-18-000628
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Schutz
Officer — Chief Executive Officer · Director
Period of report
Mar 8, 2018
Accepted (ET)
Mar 8, 2018 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Mar 8, 2018 | P | 2,473 | $3.99 | A | 35,858 | D |
Table II — derivative securities
No Table II lines on this filing.